Reading Time: 2 minutes Sadie’s recent post on the emerging partnership between Peakdale Molecular and the Sheffield Institute for Translational Neuroscience prompted me to say a little about last month’s
Category: Treatments
Reading Time: 2 minutes Thanks to funding and some strategic ‘match-making’ by the MND Association, a new drug may have taken one step closer to beginning clinical trials in
Reading Time: 3 minutes “After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see
Reading Time: 2 minutes In December last year, we told you about a new drug for uncontrollable laughter and crying (known as the pseudobulbar affect) called Nuedexta that had been approved for
Reading Time: 9 minutes I’m sure many of you who follow our blog have also been following the discussion on our forum about the Neuraltus trial for a drug called NP001.
Reading Time: 3 minutes We are aware that a number of MND organisations, forums and people living with MND have received spam messages regarding a gentleman who claims that
Reading Time: < 1 minute I’m glad to finally announce that UK recruitment for the dexpramipexole clinical trial is now open! So far, we are aware that Liverpool has opened
Reading Time: 2 minutes We have been made aware that there’s a new kid on the block in terms of unproven treatments, which is a new route of administration
Reading Time: < 1 minute We’re aware that thing’s may seem quiet in terms of ‘big’ MND research moments… almost too quiet… Well, today, the pharmaceutical companies Biogen Idec and Knopp Biosciences announced
Reading Time: 2 minutes An unproven treatment called ‘Spirulina’, which is a type of blue-green algae, has recently been investigated by ALSUntangled*. They concluded that there is no evidence